BSG consensus guidelines on the management of inflammatory bowel disease in adults are:
- Terms, clinical characteristics, and diagnosis
- Imaging-based investigations
- Surgery and acute, severe UC are all included in active UC treatment (ASUC)
- Treatment for Crohn's disease in remission (ileal, ileocolonic, colonic, jejunal, upper GI, perianal)
- Continuing care for Crohn's illness
- Crohn's disease surgery (including non-perianal fistulising disease)
- Mesalazines, corticosteroids, thiopurines, methotrexate, ciclosporin, anti-TNF, vedolizumab, ustekinumab, tofacitinib, and antibiotics are typical medication classes to be taken into account.
- Medication levels, drug toxicity/immunogenicity, pre-treatment infection screening, and vaccination are all examples of therapeutic monitoring.
- Non-drug treatments such as stem cell transplantation and leucocyte apheresis.
Learn more about inflammatory bowel disease here:
brainly.com/question/14515325
#SPJ4
Explanation:
a growing population, aging seniors, disease prevalence or incidence, medical service utilization, and service price and intensity.
Answer:
525mL
Explanation:
For every 50mL, you are repleting 50mL. This is a 1:1 ratio.
525mL divided by 50mL is 10.5. 10.5x50=525.
